Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX24 Tecovirimat
D11557 Tecovirimat hydrate (JAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D11557 Tecovirimat hydrate (JAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03049 Tecovirimat
D11557 Tecovirimat hydrate
DG03182 UGT1A4 substrate
DG03049 Tecovirimat
D11557 Tecovirimat hydrate
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Herpesvirus glycoprotein
D11557 Tecovirimat hydrate (JAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11557
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11557
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11557
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11557
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11557
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03049 Tecovirimat
DG03182 UGT1A4 substrate
DG03049 Tecovirimat